Based on observation, interview, record review, and facility policy review, the facility failed to ensure antipsychotic medications (medications used to treat serious mental illnesses) were administered only when there was an acceptable indication for use; when specific target behavioral symptoms of [CONDITION(S)] were identified and monitored; when specific side effects were monitored; and with a medical justification for duplicative medications for five of eight residents (Resident (R) 5, R6, R1, R7, and R2) out of total sample of 24 residents. This deficient practice resulted in psychosocial harm (inability to feel emotions) to R5. …
F758 citations in New York
Psychotropic drugs · Pharmacy Service Deficiencies
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
New York cites F758 less often than its own record predicts
0.29 times the national share — cited less often here than elsewhere.
Of every deficiency written in New York in 2025, this is the portion that was F758.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New York surveyors wrote
F758 findings written in New York, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on observation, interview, and record review conducted during a Standard survey completed on 4/9/2025, the facility did not ensure that residents who receive a psychotropic medication have gradual dose reductions, unless clinically contraindicated, in an effort to discontinue these drugs for one (1) (Resident #60) of five (5) residents reviewed for psychotropic medication use. Specifically, there was no gradual dose reduction attempted for a resident started on an antidepressant medication and there was no documented evidence that a gradual dose reduction was contraindicated. …
The short window
Recent years
| Year | Share of New York citations | vs expected |
|---|---|---|
| 2023 | 1.04% | 0.63× |
| 2024 | 0.60% | 0.40× |
| 2025 | 0.18% | 0.29× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else New York surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction